Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raute Sunder-Plassmann

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of the American College of Cardiology|December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trialEva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.
British Journal of Haematology|August 22, 2014
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot studySophie Brunner-Ziegler, Bernd Jilma, Dominic Magirr, et al.
Journal of the American Society of Nephrology : JASN|December 29, 2017
Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic SyndromeMartina Gaggl, Christof Aigner, Dorottya Csuka, et al.
Thrombosis and Haemostasis|December 24, 2003
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery diseaseGeorg Endler, Markus Exner, Martin Schillinger, et al.
British Journal of Haematology|April 26, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseGeorg Endler, Alexandra Klimesch, Heike Sunder-Plassmann, et al.
Thrombosis and Haemostasis|December 8, 2010
The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age)Georg Goliasch, Franz Wiesbauer, Andreas Grafl, et al.
Kidney Medicine|August 1, 2020
Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic MicroangiopathyNatalja Haninger-Vacariu, Christof Aigner, Renate Kain, et al.
Clinical Chemistry|July 16, 2005
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variantTalin Gulesserian, Catharina Wenzel, Georg Endler, et al.
Journal of Clinical Medicine|April 5, 2020
Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic MicroangiopathyChristof Aigner, Martina Gaggl, Renate Kain, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|August 23, 2011
The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophyGerald Mundigler, Martina Gaggl, Georg Heinze, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of the American College of Cardiology|December 10, 2013
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trialEva-Luise Hobl, Thomas Stimpfl, Josef Ebner, et al.
British Journal of Haematology|August 22, 2014
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot studySophie Brunner-Ziegler, Bernd Jilma, Dominic Magirr, et al.
Journal of the American Society of Nephrology : JASN|December 29, 2017
Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic SyndromeMartina Gaggl, Christof Aigner, Dorottya Csuka, et al.
Thrombosis and Haemostasis|December 24, 2003
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery diseaseGeorg Endler, Markus Exner, Martin Schillinger, et al.
British Journal of Haematology|April 26, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseGeorg Endler, Alexandra Klimesch, Heike Sunder-Plassmann, et al.
Thrombosis and Haemostasis|December 8, 2010
The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age)Georg Goliasch, Franz Wiesbauer, Andreas Grafl, et al.
Kidney Medicine|August 1, 2020
Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic MicroangiopathyNatalja Haninger-Vacariu, Christof Aigner, Renate Kain, et al.
Clinical Chemistry|July 16, 2005
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variantTalin Gulesserian, Catharina Wenzel, Georg Endler, et al.
Journal of Clinical Medicine|April 5, 2020
Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic MicroangiopathyChristof Aigner, Martina Gaggl, Renate Kain, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|August 23, 2011
The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophyGerald Mundigler, Martina Gaggl, Georg Heinze, et al.
Pageof 6